InCarda Therapeutics

📍 Newark, United States🗓 Founded 2009👥 29 employees💰 Last funded Oct 2020
Biotechnology Research🌐 incardatherapeutics.com
Website LinkedIn
InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in InCarda Therapeutics?
InCarda Therapeutics has 1 investors on record on gritt.io.
When did InCarda Therapeutics last raise funding?
The most recent investment in InCarda Therapeutics recorded on gritt.io was in October 2020.
When was InCarda Therapeutics founded?
InCarda Therapeutics was founded in 2009.
What industry is InCarda Therapeutics in?
InCarda Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is InCarda Therapeutics based?
InCarda Therapeutics is headquartered in Newark, United States.